Injective could dip further as futures Open Interest drops
Key Takeaways Injective (INJ) trades around $7.42 on Thursday, extending losses after a 5.7% decline in the previous session. The futures taker buy-to-sell ratio stands at 0.96, with sell orders accounting for 51.1% of taker activity, suggesting that sellers retain a slight advantage. A breakdown below the $7.19…
Read it in your languageMachine translation by Google of the publisher's page
From the blog
Ex-Ripple CTO Explains Why a Higher XRP Price Benefits the Network
Ripple CTO Emeritus David Schwartz explained on social media that a higher XRP price improves network utility, making liquidity more…
Elara Winter3 min read
Flare CEO Discusses Institutional Adoption and XRP Yield Reality
Flare CEO Hugo Philion discusses institutional adoption and XRP yield reality, explaining that FXRP decentralized finance growth depends on major…
Elara Winter3 min read
Analyst Egrag Crypto Explains Why XRP Trails Bitcoin and ETH Since Nov 4
Cryptocurrency analyst EGRAG CRYPTO examines why XRP is underperforming compared to Bitcoin, Ethereum, and Solana since November 4, evaluating potential…
Elara Winter3 min read